*Note* This scheduling program was not designed by folks who do a lot with APA Style and unfortunately it defaults to listing authors in alphabetical order. We cannot fix this for this online schedule, but the author orders are posted in the order submitted in the printed program available via pdf here.
Back To Schedule
Saturday, March 7 • 1:05pm - 2:05pm
Gender and Psychiatric Drug Prescriptions among Intellectually Disabled Individuals

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

The general use of psychopharmacological methods in America has been increasing over the last decade (Medco, 2011). Within the population of intellectually disabled (ID) individuals, the use of psychotropic medications has been used for those with psychological disabilities, but also as a means to subdue those who were merely difficult to manage (Tsiouris, Kim, Brown, Pettinger, & Cohen, 2012). Additional factors may also increase the use of psychotropic medications. For example, gender has often been found to influence the diagnosis, treatment, and medication of psychiatric disabilities (Bentley, 2005; Medco, 2011; Smith, 2010). The Department of Developmental Services (DDS) assists ID individuals and their families using various methods. One such method is support via assisted living residences. Within the population of those living in either state- or privately-run homes and who are taking advantage of DDS services, we examined how patterns of medication prescription according to race and gender are indicative—or not—of the US population at large. This paper is part of a larger research project examining the relationships between race, gender, and medication prescription; medications include antipsychotics, antidepressants, and anti-anxiety medications, and all prescription values refer to the quantity of drugs prescribed, but not the prescribed dosages. This presentation will focus on the findings regarding how gender appears to be related to the number of medication prescriptions within the population of ID individuals in DDS homes in Connecticut in 2013 (n = 16,694). In addition, gender can be examined with regard to only those prescribed medications. While the majority of the population was not prescribed medication, chi square analyses point to significant relationships between gender and prescriptions for antipsychotics, antidepressants, and antianxiety medications, but not for anti-mania medications or sedatives. This knowledge will help advocates better serve the ID community.

Saturday March 7, 2015 1:05pm - 2:05pm PST